Physician profile
Peter Hahn
NPI 1952742744
$17,589.93
in general payments reported to CMS, 2019-2025
13 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $974 · 2021: $105 · 2022: $189 · 2023: $2,938 · 2024: $2,258 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $2,644 · Consulting Fee: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,081.77 |
| Food and Beverage | $2,643.87 |
| Consulting Fee | $1,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $14,517.83 | 2023-2025 | Perla C, Perla Tl |
| Globus Medical, INC. | $1,492.87 | 2019-2024 | Evo Retrograde, Proximal Tibia Plate |
| Stryker Corporation | $508.26 | 2019-2025 | T2 Alpha, T2, Gamma |
| US Implant Solutions, LLC | $219.43 | 2024 | |
| Zimmer Biomet Holdings, INC. | $190.91 | 2021-2023 | Stratum Foot Plating System |
| Orthopediatrics Corp. | $171.46 | 2020-2022 | |
| Bone Support INC. | $132.16 | 2025 | Cerament G, Ceramentbone Void Filler |
| Medical Device Business Services, INC. | $123.09 | 2019 | |
| Nuvasive, INC. | $108.41 | 2019 | |
| Baxter Healthcare | $51.68 | 2025 | Floseal |
| Depuy Synthes Sales INC. | $33.09 | 2019 | |
| Medtronic, INC. | $23.94 | 2022 | |
| Biomarin Pharmaceutical INC. | $16.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.